The platform starts with potassium but scales to forty markers. This breadth is impressive compared to single-marker devices. It offers more versatility for users who need varied biomarker data.
Questions about BioSync
What is BioSync?
BioSync is a wellness product that provides pocket-sized biomarker readings outside of laboratory settings using a needle-free method. The device delivers a result in about 90 seconds, starting with potassium and planned to expand to over 40 biomarkers by Series A. The company is currently raising a seed funding round and is based in Timișoara, Romania.
How does the BioSync system work?
The platform uses a two-part system consisting of a capture pen called BIO and a pocket reader called SYNC. Users place a small saliva sample on the BIO pen, dock it into the SYNC reader, and receive results in the app within approximately ninety seconds.
Which biomarkers are currently available or in development?
The device measures potassium live today, with sodium, cortisol, testosterone, and estrogen listed as targets in development. The company states that the same reader scales along a roadmap to reach past 40 markers by Series A.
What market statistics does BioSync cite?
The website mentions a shift in the testing market from $44 billion to $125 billion by 2034 with a 12.2% CAGR. It also notes that 14 billion lab tests are run every year in the US alone, highlighting the need for point-of-care testing.
Where is BioSync located and what is its current status?
The company is located in Timișoara, Romania, and is described as pre-revenue. They are actively seeking investment, partnerships, and early access through direct contact.
How can people get involved with BioSync?
To get involved, users can start a specialist interview or a fan interview, each taking about 40 minutes and consisting of 10 questions. Specialists include doctors, coaches, nutritionists, and pharmacists, while fans include athletes and quantified-self users.
Who is BioSync targeting for validation and development?
The company is raising a seed funding round and is being validated with clinicians, coaches, athletes, and enthusiasts who judge the science and live the use case.
What are the key features of the BioSync device?
The device is needle-free and non-invasive, allowing users to take a sample anywhere without a clinic or lab. The entire process from capture to result takes about ninety seconds.
How does BioSync personalize the user experience?
The company states that the app does not just measure but learns the user, tuning to their normal over time to spot changes and provide personalized guidance.
What are the terms of use for BioSync?
The company explicitly states that the system is not intended to diagnose, treat, cure, or prevent any disease, and that readings support everyday awareness.
What is the official website of BioSync?
The official website of BioSync is bio-sync.health.
How is BioSync rated on Trustburn?
On Trustburn, BioSync has a rating of 4.2 out of 5 based on 5 reviews.
AI-generated from reviews on this page. Verify anything important with the company directly.
BioSync offers a compelling pocket biomarker platform. The needle-free approach and quick ninety-second reading time are impressive features that simplify health monitoring.
The scope of the BioSync system appears robust. Starting with potassium provides a useful baseline, while the potential to scale past forty markers offers significant versatility. This breadth supports comprehensive health tracking from a single pocket-sized device. The ability to monitor multiple biomarkers without laboratory equipment simplifies data collection. For someone interested in longitudinal health data, this wide range of available markers is a strong feature. It suggests a platform designed for thoroughness rather than just single-use testing.
I am absolutely thrilled by the prospect of BioSync bringing biomarkers out of the lab and into your hand! The idea of a needle-free, ninety-second reading is revolutionary. Starting with potassium and scaling past forty markers shows incredible ambition. The preorder option makes this accessible now. I really hope the team delivers on this promise of easy, rapid health insights. The convenience of checking multiple markers quickly without a clinic visit would be a game-changer for daily health management. This technology seems poised to democratize health monitoring significantly for everyone.
The pricing looks very reasonable for a pocket biomarker platform. I am curious if the preorder cost includes the initial potassium test or just the device hardware.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About BioSync
BioSync is developing a pocket-sized biomarker platform intended to provide health readings outside of laboratory settings. The device uses a needle-free method to deliver a reading in about 90 seconds. According to the company, the initial marker being measured is potassium, with plans to expand coverage to more than 40 biomarkers. The website indicates that preorders are available and that the company is currently raising a seed funding round.
- Website
- bio-sync.health
- Categories
- Hospital & health care, Medical devices, Biotechnology